UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$495M |
| 2 |
Microsoft
MSFT
|
+$480M |
| 3 |
Global Payments
GPN
|
+$400M |
| 4 |
Mastercard
MA
|
+$274M |
| 5 |
Comcast
CMCSA
|
+$254M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSS
Total System Services, Inc.
TSS
|
+$225M |
| 2 |
WP
Worldpay, Inc.
WP
|
+$190M |
| 3 |
Apple
AAPL
|
+$167M |
| 4 |
RHT
Red Hat Inc
RHT
|
+$166M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Financials | 14.07% |
| 3 | Healthcare | 13.13% |
| 4 | Consumer Discretionary | 12.1% |
| 5 | Communication Services | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SVM
2201
Silvercorp Metals
SVM
$2.53B
| $558K | ﹤0.01% |
143,631
+21,231
| +17% | +$76K |
|
2202
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24.5B
| $557K | ﹤0.01% |
3,059
-8
| -0.3% | -$1.49K |
|
2203
Expro Ltd
XPRO
$1.91B
| $556K | ﹤0.01% |
19,524
+1,160
| +6% | +$35.4K |
|
2204
Quanex
NX
$1.01B
| $555K | ﹤0.01% |
30,677
+15,819
| +106% | +$284K |
|
|
HTB
2205
HomeTrust Bancshares
HTB
$850M
| $554K | ﹤0.01% |
21,233
+10,133
| +91% | +$258K |
|
2206
Mesa Laboratories
MLAB
$574M
| $551K | ﹤0.01% |
2,319
+1,226
| +112% | +$283K |
|
|
NGD
2207
DELISTED
New Gold Inc
NGD
| $551K | ﹤0.01% |
548,533
+118,086
| +27% | +$144K |
|
|
HTBK
2208
DELISTED
Heritage Commerce
HTBK
| $551K | ﹤0.01% |
46,864
+2,572
| +6% | +$30.6K |
|
2209
Team
TISI
$77.7M
| $549K | ﹤0.01% |
3,043
+1,469
| +93% | +$243K |
|
|
PEI
2210
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $547K | ﹤0.01% |
6,377
-7,955
| -56% | -$674K |
|
2211
Precigen
PGEN
$2.59B
| $547K | ﹤0.01% |
95,646
+15,917
| +20% | +$108K |
|
|
XOG
2212
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
| $546K | ﹤0.01% |
185,771
+83,313
| +81% | +$316K |
|
2213
Adtran
ADTN
$616M
| $545K | ﹤0.01% |
48,051
+8,550
| +22% | +$102K |
|
2214
Hackett Group
HCKT
$287M
| $545K | ﹤0.01% |
33,106
+4,410
| +15% | +$72.5K |
|
2215
Evolent Health
EVH
$444M
| $542K | ﹤0.01% |
75,324
+19,668
| +35% | +$141K |
|
2216
Pacific Biosciences
PACB
$370M
| $541K | ﹤0.01% |
104,795
+9,276
| +10% | +$51.9K |
|
|
MAGN
2217
Magnera Corp
MAGN
$460M
| $540K | ﹤0.01% |
2,698
+1,090
| +68% | +$218K |
|
2218
AngioDynamics
ANGO
$649M
| $539K | ﹤0.01% |
29,253
+7,469
| +34% | +$146K |
|
|
ATNX
2219
DELISTED
Athenex, Inc. Common Stock
ATNX
| $538K | ﹤0.01% |
2,213
+459
| +26% | +$150K |
|
|
CCF
2220
DELISTED
Chase Corporation
CCF
| $537K | ﹤0.01% |
4,912
+2,845
| +138% | +$291K |
|
2221
TTEC Holdings
TTEC
$124M
| $536K | ﹤0.01% |
11,199
+5,200
| +87% | +$244K |
|
2222
Gates Industrial Corporation Ltd.
GTES
$7.15B
| $534K | ﹤0.01% |
53,062
+24,162
| +84% | +$237K |
|
2223
Opko Health
OPK
$1.02B
| $530K | ﹤0.01% |
253,699
+38,708
| +18% | +$79.1K |
|
|
CSW
2224
CSW Industrials
CSW
$5.71B
| $530K | ﹤0.01% |
7,675
+3,938
| +105% | +$272K |
|
|
DO
2225
DELISTED
Diamond Offshore Drilling
DO
| $528K | ﹤0.01% |
94,874
-24,258
| -20% | -$177K |
|
Similar funds
UBS AM's Q3 2019 Portfolio in Review
As of Q3 2019, UBS AM held 2,935 positions worth $148B, up 5.8% from $140B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM deployed $6.46B of net new capital in Q3 2019, opening 79 new positions and adding to 1,853 existing holdings. Its largest new stake was 10x Genomics: 184,683 shares worth $9.31M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $167M trimmed.
- UBS AM's largest Q3 2019 buy was 10x Genomics: 184,683 shares worth $9.31M.
- UBS AM added most to Alibaba in Q3 2019, an estimated $495M increase.
- UBS AM's biggest Q3 2019 reduction was Apple, cutting an estimated $167M.
- UBS AM fully exited Total System Services, Inc. in Q3 2019, selling an estimated $225M.
- UBS AM's ten largest holdings make up 19% of its $148B portfolio in Q3 2019.
- UBS AM opened 79 new positions and closed 50 in Q3 2019.
- UBS AM's portfolio value rose 5.8% quarter-over-quarter to $148B.
Based on UBS AM's 13F filing for Q3 2019, filed 14 Nov 2019.